INT230359

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.11
First Reported 2008
Last Reported 2010
Negated 3
Speculated 0
Reported most in Body
Documents 3
Total Number 7
Disease Relevance 1.98
Pain Relevance 0.58

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Tas (Mus musculus)
Pain Link Frequency Relevance Heat
diclofenac 70 99.42 Very High Very High Very High
Dopamine 50 83.08 Quite High
monoamine 3 73.64 Quite High
anesthesia 20 50.80 Quite High
cINOD 5 46.72 Quite Low
Inflammation 7 5.00 Very Low Very Low Very Low
imagery 3 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
ketamine 1 5.00 Very Low Very Low Very Low
dopaminergic neurodegeneration 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Stress 116 99.16 Very High Very High Very High
Neurological Disease 1 98.94 Very High Very High Very High
Disease 29 98.40 Very High Very High Very High
Gallstones 15 65.44 Quite High
Umbilical Hernia 5 65.12 Quite High
Pneumoperitoneum 55 56.40 Quite High
Mental Disorders 72 50.00 Quite Low
Hernia 15 49.80 Quite Low
Cancer 10 32.44 Quite Low
Anaemia 5 29.72 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In contrast, no significant changes in TOS, TAS, PON1, and arylesterase activities were observed in Group II.
Neg (no) Regulation (changes) of TAS
1) Confidence 0.11 Published 2010 Journal Clinics (Sao Paulo) Section Body Doc Link PMC2845769 Disease Relevance 0.63 Pain Relevance 0
In addition, no significant changes in TOS, TAS, PON1, and arylesterase activities were noticed in Group II.
Neg (no) Regulation (changes) of TAS
2) Confidence 0.11 Published 2010 Journal Clinics (Sao Paulo) Section Body Doc Link PMC2845769 Disease Relevance 0.25 Pain Relevance 0
In our study, TOS levels in patients that underwent LC slightly increased during the perioperative period and on postoperative day 1, while TAS levels in this group slightly decreased; however, the changes in the levels of both TOS and TAS were not statistically significant.
Regulation (changes) of TAS
3) Confidence 0.07 Published 2010 Journal Clinics (Sao Paulo) Section Body Doc Link PMC2845769 Disease Relevance 0.45 Pain Relevance 0
Mean and SD values of PON1 and arylesterase activities, as well as TAS and TOS levels are presented in Table 2.
Regulation (values) of TAS
4) Confidence 0.07 Published 2010 Journal Clinics (Sao Paulo) Section Body Doc Link PMC2845769 Disease Relevance 0.16 Pain Relevance 0.05
In contrast, TAS levels did not change significantly.
Neg (not) Regulation (change) of TAS
5) Confidence 0.05 Published 2010 Journal Clinics (Sao Paulo) Section Body Doc Link PMC2845769 Disease Relevance 0.20 Pain Relevance 0
However, our data raised the question whether the enhanced extracellular concentrations of TAs following chronic DCF treatment might be associated with a risk of neurological disorders for patients taking DCF over a prolonged period, as TAs dysregulation has been linked to various psychiatric diseases (Lindemann and Hoener 2005).
Regulation (dysregulation) of TAs associated with neurological disease, disease and diclofenac
6) Confidence 0.04 Published 2008 Journal Journal of Neurochemistry Section Body Doc Link PMC2324205 Disease Relevance 0.28 Pain Relevance 0.53
Note that the average gross price is considerably less in the other two regions, Tas. and Qld.
Regulation (less) of Tas
7) Confidence 0.03 Published 2008 Journal Int J Ment Health Syst Section Body Doc Link PMC2459150 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox